Company ProfilePremium

Kelfred Holdings Limited

Company Profile Analysis

Ticker: 1134.HK恒發光學控股有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Kelfred Holdings Limited - Company showcase

Year Founded & Workforce

1986

768 Employees

Kelfred Holdings Limited logo

Kelfred Holdings Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Kelfred Holdings Limited Overview

Kelfred is a small-cap, Hong Kong-headquartered contract manufacturer of eyewear — spectacle frames and sunglasses — producing primarily on an ODM/OEM basis for international eyewear retailers, trading houses and licensed brand owners, with a minor own-brand line ("Miga"). Manufacturing is concentrated in two PRC bases (Shenzhen, from 2013; a self-owned Jiangxi base, from 2016), with a third base in Thailand slated to start production in H2 2026 to diversify away from China-origin tariff and cost exposure. Europe is the dominant end-market, with Italy and the UK together accounting for roughly 57% of H1 2026 deliveries. FY2025 revenue was HK$500.3m, but gross margins have compressed from ~16% in FY2022 to 10.5% in H1 2026, and the group has posted losses since FY2024. In mid-2026 the founding Kwok family fully exited its shareholding, leaving a fragmented new shareholder base and an open question over strategic direction and "diversification".


Company's own description (latest annual report)

In its FY2025 annual report, the company describes itself as an established eyewear manufacturer in the PRC and Hong Kong producing and selling a wide range of spectacle frames and sunglasses, mainly through ODM and OEM business models, and offering integrated customised services spanning product design and development, raw-material procurement, production, quality control, packaging and delivery. It additionally sells OBM products under the "Miga" brand. It emphasises over 30 years of industry experience and a customer network of international eyewear retailers, trading companies and licensed brand owners, with Europe as its largest market [AR2025]. The FY2025 report states the first major production base was set up in Shenzhen in 2013 and a second, self-owned base in Jiangxi in 2016, with a third base in Thailand expected to be set up in 2026 [AR2025]; the H1 2026 report updates this to production readiness expected in H2 2026 [IR2026].

Business model and revenue model

DimensionCharacterisationEvidence
Core modelContract manufacturing (ODM/OEM) of eyewear under customers' brands[AR2025]
Own-brandOBM under "Miga" — immaterial; revenue not separately disclosed[AR2025]
Revenue type100% product sales, recognised at a point in time on delivery[IR2026] note 4
Service/licensing revenueNone in revenue line; ancillary design, service, sample/mould fees booked in "other income" (HK$4.9m combined in H1 2026)[IR2026] note 5
Subscription——
Operating segmentSingle segment: design, manufacture and sale of eyewear[IR2026] note 4

Value chain position

Kelfred sits in the upstream manufacturing tier of the eyewear value chain: it designs (ODM) or builds to specification (OEM), procures materials (suppliers mainly PRC-based [IR2026]), manufactures and ships to brand owners/distributors who own the consumer relationship. It does not operate retail, does not hold major licences, and captures a thin manufacturing margin — 11.9% gross margin in FY2025 and 10.5% in H1 2026 [AR2025], [IR2026]. A related party controlled by the CEO, DEM FACTORY SRL (Italy), assembles frames/sunglasses using Italian suppliers and buys a small amount of product from the group (HK$1.6m in H1 2026) [IR2026].

Customer types and concentration

Customer (anonymised)H1 2024H1 2025H1 2026
Customer A revenue (HK$ m)44.074.468.4
Customer A % of revenue (derived)22.330.731.1
Customer B revenue (HK$ m)31.834.228.9
Customer B % of revenue (derived)16.114.113.2
Customer C revenue (HK$ m)22.933.811.2
Customer C % of revenue (derived)11.614.05.1
Top-3 % of revenue (derived)50.058.849.4

Customers are primarily international eyewear retailers, trading companies and licensed brand owners [AR2025]. Concentration is high:

Sources: [IR2025], [IR2026]. Customer C fell below the 10% threshold in H1 2026.

End-markets

Delivery destinations are overwhelmingly Europe (Italy, UK, Spain, Sweden) and Hong Kong (likely trading-house intermediated re-exports), with smaller US, PRC, Japan and Philippines volumes [IR2026]. The company has stated it sold to over 35 countries in recent years [IR2025].

Independent characterisation

Kelfred is a sub-scale, price-taking ODM/OEM supplier in a fragmented, China-centric frame-manufacturing industry. Its economics are driven by (i) order volume from a handful of European customers, (ii) average selling price pressure, (iii) RMB/HKD exchange rates (costs in RMB, sales largely in USD/EUR/HKD), and (iv) labour productivity. The group lacks proprietary brands, licences or technology that would provide pricing power. Its balance sheet is ungeared (net cash, lease-only debt at period-ends) but working capital is funded partly through receivables factoring and short-term secured RMB bank loans drawn and repaid within each year. The July 2026 ownership change makes the investment case increasingly about corporate control and potential re-purposing of the listed vehicle rather than eyewear fundamentals alone.

Strategy

Stated strategy themes (latest annual and interim reports, paraphrased)

From the FY2025 Chairman's Statement and MD&A and the H1 2026 MD&A [AR2025], [IR2026]:

  1. Cost control — continue to strengthen cost-saving measures and streamline operations.

  2. Order capture — win more orders by supplying quality products.

  3. Capacity and design — raise competitiveness by enhancing production capacity and creating more innovative designs.

  4. Geographic manufacturing diversification — establish the Thailand production base.

  5. Supply-chain optimisation.

  6. Sustainability — integrate sustainability principles into business practices (no quantified targets).

  7. Business diversification — eyewear remains the core, while management keeps exploring opportunities to diversify income streams. The board reiterated this after the July 2026 change in substantial shareholder [ANN-29JUL26].

The Chairman characterised the stance for 2026 as prudent and cautious [AR2025].

Initiative register (last 24 months)

InitiativeAnnouncedStatusTargets disclosedSource
Thailand production baseMar 2026 (FY2025 results)Being set up; THB leases signed; 5 staff; production expected H2 2026None (capex, capacity not disclosed)[AR2025], [IR2026]
Cost-saving programmeOngoing since 2024PRC headcount down ~26% Dec 2024→Jun 2026; staff costs FY2025 HK$107.1m vs HK$129.3m FY2024No quantified target[AR2025], [IR2026]
Marketing push (incl. own-brand)2025–26Advertising and promotion +HK$3.7m in FY2025; selling costs +41% in H1 2026—[AR2025], [IR2026]
Design/services monetisation2025–26Design + service fees rising (see Section 5)—[IR2026]
DiversificationOngoingNo transaction announced—[IR2026]

Medium-term financial targets / guidance

None disclosed. The company provides only qualitative outlook: a challenging environment into H2 2026 and 2027 due to trade frictions and geopolitics [IR2026]. No investor day has been held (none identified).

Products & Services

Kelfred does not publish a SKU-level catalogue in its periodic filings; product-material mix, unit volumes, ASPs and named customer programmes are not publicly disclosed in the filings reviewed. The portfolio as disclosed is set out below.

Analyst note. The rising share of design and service fees (combined design + product services + samples/moulds HK$4.9m in H1 2026 vs HK$2.7m in H1 2025) suggests Kelfred is trying to monetise its ODM design capability separately as unit pricing weakens. It remains small relative to revenue (~2.2%).

Product Portfolio

Product / serviceDescriptionTarget customerBusiness modelPricing modelDisclosed revenueSource

Optical spectacle frames

Prescription-ready frames manufactured to customer designs (OEM) or Kelfred designs (ODM)

International eyewear retailers, trading companies, licensed brand owners

ODM/OEM

Per-unit contract pricing; ASP declining in 2025–26

Not split; within HK$219.6m H1 2026 eyewear sales

[IR2026]

Sunglasses

Non-prescription sun eyewear under customer brands

Same

ODM/OEM

Per-unit contract pricing

Not split

[IR2026]

"Miga" own-brand eyewear

Original brand manufacturing line

—

OBM

—

Not disclosed (immaterial)

[AR2025]

Product design services

Design work charged to customers

ODM customers

Fee

Per-project fee

HK$2.14m (H1 2026); HK$1.69m (H1 2025); HK$0.12m (H1 2024) — in other income

[IR2026], [IR2025]

Product services

Service fees (nature not detailed)

Customers

Fee

—

HK$2.33m (H1 2026); HK$0.82m (H1 2025)

[IR2026]

Samples and moulds

Sample/mould making charged to customers

Customers

Fee

Per item

HK$0.45m (H1 2026); HK$0.21m (H1 2025)

[IR2026]

Material re-charges

Materials charged on to customers

Customers

Pass-through

Cost-plus

HK$1.28m (H1 2026)

[IR2026]

Scrap sales & rework

Sale of scrap and rework services

—

Ancillary

—

HK$0.11m (H1 2026)

[IR2026]

“—” = not publicly disclosed.

Financial Narrative

Income statement

Sources: [AR2025] five-year summary; D&A from [SA]; EPS derived on 500m shares (FY2025 −3.02 cents confirmed in results coverage).

Margins and growth

Revenue CAGR (derived): FY2021–FY2025 ≈ 3.6% p.a.; FY2017–FY2025 ≈ 4.1% p.a.

Commentary. The defining trend is margin destruction rather than revenue decline. Revenue in FY2025 (HK$500.3m) was a record, yet gross margin was ~4.4 points below FY2022. Management attributes the FY2024 collapse (GM 9.8%) to lower ASPs and cost pressure, the FY2025 partial recovery to higher order volumes and cost-saving measures, and the H1 2026 relapse (GM 10.5%) to competitive ASP declines plus RMB appreciation [AR2025], [IR2026]. "Other income" has been a material swing factor: in FY2023 it contributed HK$24.1m — more than six times the operating profit — and its normalisation explains much of the FY2024 loss; in 2025–26 it has been depressed by FX losses (H1 2026 net FX loss HK$3.1m) [IR2026]. Admin costs have been held flat at ~HK$60–62m for five years, so the business has very limited operating leverage at current gross margins: break-even at the operating line would require gross margin around 15% on FY2025 revenue (derived).

Balance sheet

Sources: [AR2025], [IR2025], [IR2026]; FY2023 cash from opening balance in [IR2025] cash flow; FY2023 debt derived from 8.3% gearing [AR2024s]. Year-end debt consists of lease liabilities only; however, the group draws secured short-term RMB bank loans each July and January and repays them within the year (e.g., RMB5.0m and RMB18.95m drawn in July 2026), so intra-year debt is higher than year-end snapshots suggest [IR2026] note 19. Goodwill/intangibles: none shown in the condensed balance sheet [IR2026].

Latest interim balance sheet (30 Jun 2026): total assets HK$257.3m; net assets HK$141.7m; cash HK$29.9m; lease liabilities HK$7.6m; inventories HK$68.3m; trade receivables HK$101.8m; trade payables HK$87.0m; net current assets HK$110.9m; current ratio 2.0x; quick ratio 1.4x; gearing 5.3% [IR2026].

Cash flow

Sources: [SA] for OCF and capex (secondary aggregator of filed statements); buybacks nil per [AR2025] and prior reports' statements of no repurchases (FY2025, FY2024 confirmed; earlier years per absence of share count changes).

Interim cash flow: H1 2026 operating cash outflow HK$13.1m vs inflow HK$5.9m in H1 2025; capex HK$1.5m; net decrease in cash HK$18.4m [IR2026].

Commentary. FY2025's HK$28.4m OCF despite a HK$15.2m loss was flattered by working-capital release (inventory −HK$11.4m) and heavier receivables factoring: factored and derecognised receivables rose from HK$39.4m (Dec 2024) to HK$102.4m (Dec 2025), then fell to HK$44.5m (Jun 2026) [IR2025], [IR2026]. The H1 2026 operating outflow partly reflects that unwind. Underlying cash generation is therefore weaker than headline FY2025 FCF implies.

Ratios

Sources: [AR2025], [AR2024s] (FY2023 current/quick/gearing from comparatives), derived. ROIC uses operating profit taxed at 16.5% where positive; where negative, operating loss is used untaxed. Net debt/EBITDA for FY2025 is mechanically extreme because EBITDA is near zero; it is not economically meaningful. Receivable days are understated by factoring.

Trend, inflection and driver commentary

FY2021 (recovery): Revenue rebounded 22.7% post-COVID; still loss-making due to cost base. Management also explored NEV diversification (placing and MOU) [AR2021], [ANN-JUN21], [ANN-JUL21].

FY2022 (peak profitability post-IPO): GM 16.3%, profit HK$9.2m supported by HK$13.1m other income [AR2022], [AR2025].

FY2023 (volume shock): Revenue −15.5% on European weakness; profit held positive only via HK$24.1m other income [AR2023], [AR2025].

FY2024 (margin collapse): Volume recovered (+15.3%) but GM fell to 9.8%; net loss HK$21.6m [AR2024s].

FY2025 (partial repair): Volume growth plus cost saving lifted GP 32.7%; loss narrowed to HK$15.2m but FX turned negative as RMB appreciated [AR2025].

H1 2026 (relapse): Revenue −9.5% on ASP pressure; GM 10.5%; selling costs +41% (advertising/promotion); loss widened to HK$12.1m [IR2026].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment and Segment Margins & Growth (%)

SegmentFY2021FY2022FY2023FY2024FY2025

Eyewear products revenue (HKD Mn)

434.7465.4393.3453.6500.3

Eyewear products YoY growth (%)

22.77.1-15.515.310.3

Eyewear products pre-tax profit (HKD Mn)

-1.610.72.2-21.4-13.7

Eyewear products pre-tax margin (%, derived)

-0.42.30.6-4.7-2.7

Share of group revenue (%)

100100100100100

Results by Segment and Segment Margins & Growth (%)

MetricH1 2024H2 2024H1 2025H2 2025H1 2026

Revenue (HKD Mn)

197.4256.2242.5257.7219.6

Gross profit (HKD Mn)

17.826.931.228.123.0

Gross margin (%)

9.010.512.910.910.5

Net profit (HKD Mn)

-12.3-9.4-4.7-10.4-12.1

Group Entities

EntityLocationRole (as disclosed/inferred)Source

Kelfred Holdings Limited

Cayman Islands

Listed investment holding company

[IR2026]

Huaqing Glasses (Shenzhen) Company Limited

Shenzhen, PRC

Manufacturing; High and New Technology Enterprise (15% tax rate)

[IR2026] note 7

Jiangxi Huaqing Glasses Co., Limited

Jiangxi, PRC

Manufacturing (self-owned base); R&D super-deduction claimant

[IR2026] note 7

Yingtan Euro-Asia Enterprise Limited

Yingtan, Jiangxi, PRC

Small and Low-profit Enterprise (20% preferential rate)

[IR2026] note 7

東宇科技有限公司 (Dongyu Technology Limited)

Hong Kong (directly wholly-owned per 2021 announcement)

Vehicle used for 2021 NEV MOU

[ANN-JUL21]

Thailand operating subsidiary

Thailand

Third production base; name not disclosed in documents reviewed. Non-controlling interests first appeared in FY2025 (−HK$47k), consistent with a non-wholly-owned new subsidiary (analyst inference, unconfirmed)

[AR2025], [IR2026]

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (HKD Mn)

434.7465.4393.3453.6500.3

Cost of sales (HKD Mn)

366.3389.4336.3408.9440.9

Gross profit (HKD Mn)

68.476.057.044.759.3

Other income gains and losses (HKD Mn)

5.313.124.112.86.4

Selling and distribution expenses (HKD Mn)

13.814.617.114.816.9

Administrative and other opex (HKD Mn)

60.963.660.262.060.5

Operating profit (HKD Mn)

-1.111.43.9-19.5-11.1

D&A (HKD Mn, aggregator)

14.29.710.412.211.4

EBITDA (HKD Mn, derived)

13.121.114.2-7.30.3

Finance costs (HKD Mn)

0.50.71.72.02.6

Pre-tax profit (HKD Mn)

-1.610.72.2-21.4-13.7

Income tax (HKD Mn)

0.61.50.80.21.4

Net profit (HKD Mn)

-2.19.21.4-21.6-15.2

Net profit attributable to owners (HKD Mn)

-2.19.21.4-21.6-15.1

EPS basic and diluted (HK cents)

-0.431.840.28-4.33-3.02

Dividend per share (HK cents)

———00

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

15.716.314.59.811.9

Operating margin (%)

-0.22.41.0-4.3-2.2

EBITDA margin (%, derived)

3.04.53.6-1.60.1

Net margin (%)

-0.52.00.4-4.8-3.0

Revenue growth (%)

22.77.1-15.515.310.3

Opex to revenue (%, derived)

17.216.819.716.915.5

Balance Sheet

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (HKD Mn)

268.1251.9264.0282.9282.8

Total liabilities (HKD Mn)

81.865.380.8126.5134.4

Total equity (HKD Mn)

186.3186.6183.2156.4148.5

Cash and bank balances (HKD Mn)

——20.327.848.0

Total debt incl. leases (HKD Mn)

——15.212.68.5

Short-term debt (HKD Mn)

———3.43.5

Long-term debt (HKD Mn)

———9.25.0

Net debt (HKD Mn, negative = net cash)

——-5.1-15.3-39.5

Goodwill and intangibles (HKD Mn)

00000

Net current assets (HKD Mn)

———121.9117.9

Inventories (HKD Mn)

———85.874.7

Trade receivables (HKD Mn)

———116.8113.4

Trade payables (HKD Mn)

———91.298.8

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (HKD Mn)

-21.919.3-4.617.528.4

Capex (HKD Mn)

5.14.715.75.02.4

Free cash flow (HKD Mn, derived)

-27.014.6-20.312.525.9

Dividends paid (HKD Mn)

———00

Share buybacks (HKD Mn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE (%, net profit / closing equity, derived)

-1.14.90.8-13.8-10.2

ROA (%, net profit / closing assets, derived)

-0.83.60.5-7.6-5.4

ROIC (%, derived approx: NOPAT / (equity + debt − cash))

——1.8-14.4-11.0

Current ratio (x)

——3.12.01.9

Quick ratio (x)

——2.01.31.3

Debt to equity (%)

——8.38.05.7

Net debt to EBITDA (x, derived)

——-0.4—-131.7

Interest coverage (x, EBIT / finance cost, derived)

-2.115.42.3-9.8-4.2

Asset turnover (x, derived)

1.621.851.491.601.77

Inventory days (derived)

———76.661.8

Receivable days (derived)

———94.082.7

Payable days (derived)

———81.481.8

Cash conversion cycle (days, derived)

———89.262.7

Revenue by Region

RegionH1 2024H1 2025H1 2026

Italy (HKD Mn)

87.884.570.8

United Kingdom (HKD Mn)

52.270.955.4

Hong Kong (HKD Mn)

36.865.754.4

United States (HKD Mn)

6.911.27.9

Japan (HKD Mn)

2.82.91.8

All other destinations (HKD Mn, derived residual)

10.97.329.3

Total (HKD Mn)

197.4242.5219.6

Geographic Revenue

RegionH1 2025 YoY growth (%)H1 2026 YoY growth (%)H1 2026 share of revenue (%)

Italy

-3.7-16.232.2

United Kingdom

35.9-21.825.2

Hong Kong

78.7-17.224.8

United States

62.2-29.33.6

Japan

3.1-38.10.8

All other (derived)

-33.4302.413.3

Geographic Revenue (H1 2025 (HKD Mn)–H1 2026 (HKD Mn))

CountryH1 2025 (HKD Mn)H1 2026 (HKD Mn)Comment

Spain

0.014.9

New material market; 6.8% of H1 2026 revenue

PRC

1.85.7

Domestic sales tripled

Philippines

0.02.8

New

Sweden

0.12.6

New

Others

5.33.3

Residual as reported

Locations

Location31 Dec 202430 Jun 202531 Dec 202530 Jun 2026

Hong Kong (HKD Mn)

2.61.71.11.4

PRC (HKD Mn)

39.935.032.330.2

Thailand (HKD Mn)

0.00.01.41.1

Share Price History

DatePrice (HKD)Implied market cap (HKD Mn)Source

16 Jul 2019 (IPO)

1.00500

[IPO2019]

4 Jun 2021 (pre-placing close)

1.55775

[ANN-JUN21]

~May 2025

~0.17

~86

Market data summary (TipRanks)

~Aug 2025

~0.19

~94.5

Market data summary (TipRanks)

23 Apr 2026

0.30150

etnet quote

31 Jul 2026

0.33165

[SA]

Return measure (approximate, to 31 Jul 2026)

Value (%)

——

~1-year (from ~HK$0.19, Aug 2025)

74——

~5-year (from HK$1.55, Jun 2021)

-79——

Since IPO (HK$1.00)

-67——

Valuation Multiples

MultipleKelfredArts Optical (1120.HK)Sun Hing (0125.HK)

Market cap (HKD Mn)

16534878

P/E (x)

n/m (TTM loss ≈ HK$22.5m)

~16.8

n/m (loss)

EV/EBITDA (x)

n/m (TTM EBITDA ≈ −HK$9.4m)

—

n/m

EV/Sales (x)

~0.30 (EV ≈ HK$143m pre post-period loans; TTM revenue HK$477.3m)

~0.26 (P/S basis)

~0.09 (P/S basis)

P/B (x)

~1.16 (NAV HK$141.7m)

——

Analyst Conclusions

Management guidance

Qualitative only: the environment remains challenging into H2 2026 and 2027 due to trade frictions and geopolitics; continued cost saving, supply-chain optimisation, innovative designs, Thailand ramp-up and diversification exploration [IR2026]. No numerical guidance.

Consensus growth expectations

None available.

Bull case

  1. Thailand unlocks tariff-advantaged orders: with US deliveries already down 29% in H1 2026, a non-China base could recapture US and tariff-sensitive European programmes and support ASPs [IR2026].

  2. Operating leverage on recovery: admin costs flat at ~HK$60m for five years; a return to FY2022's 16% gross margin on FY2025 revenue would add ~HK$21m gross profit and restore operating profit (derived) [AR2025].

  3. Corporate-control optionality: a fragmented new register (59.19% held by three new holders) and a net-cash, ungeared listed vehicle trading near 1.2x book create scope for capital injection, asset injection or strategic redirection [IR2026].

Bear case

  1. Structural margin erosion: ASP declines and RMB strength compressed GM to 10.5% in H1 2026, eliminating most of the FY2025 repair; peers face the same pressure [IR2026], [PEER].

  2. Cash runway is finite: cash fell to HK$29.9m with an H1 2026 operating outflow of HK$13.1m, and seasonal borrowing needs have risen (RMB18.95m July 2026 loan) [IR2026].

  3. Governance discontinuity: the operating management (Kwok brothers) no longer has an ownership stake, while new holders' intentions are undisclosed — raising the risk of management departures, customer disruption, or a non-eyewear pivot with dilution [ANN-29JUL26], [IR2026].

Catalysts and monitorables (next 12 months)

Catalyst / monitorableTimingWhy it matters
Thailand base start of productionH2 2026Tests the diversification thesis
FY2026 annual results~Mar 2027H2 margin trajectory; FX; full-year country mix
Board/management changes following ownership transferAny timeSignals new holders' strategy; Kwok brothers' continuity
Any capital raising under general mandateAny timeDilution vs fresh capital
Substantial-shareholder moves near 30% Takeovers Code threshold (Hu Xing at 29.59%)Any timePotential general offer dynamics
Customer A/B/C order trendsInterim/annualConcentration risk
RMB/HKD exchange rateContinuousDirect gross-margin and FX-line impact
Factoring utilisation and seasonal borrowingsInterim/annualLiquidity quality

Analyst verdict

Kelfred Holdings is, at its core, a sub-scale Chinese eyewear ODM/OEM supplier whose economics have deteriorated materially since its 2019 listing. Revenue has grown only ~3.6% a year since FY2021 and reached a record HK$500.3m in FY2025, yet gross margin has fallen from 16.3% (FY2022) to 10.5% (H1 2026), and the group has lost money in every reported period since the start of FY2024. Management's levers — cost cutting, design-fee monetisation, new markets such as Spain, and a Thailand production base — are sensible but incremental, and none has yet offset ASP deflation, RMB appreciation and soft European demand. The balance sheet remains a genuine positive: no financial debt at period-ends, net cash, and an owned Jiangxi facility that can be pledged. But cash dropped by over a third in H1 2026, and working capital leans on factoring and short-term secured loans.

The more consequential development is outside the P&L. Between April and July 2026 the founding Kwok family sold its entire 54.19% stake; the register is now led by Ms. Hu Xing (29.59%), executive director Liu Zhen (19.60%) and Ms. Tam Man Yee (10.00%), and the company states there is no controlling shareholder. The share price has roughly doubled from mid-2025 lows, and the stock now trades at ~1.2x book and ~0.3x sales despite losses — a valuation that only makes sense if investors are paying for control optionality. The investment case has therefore shifted from "eyewear turnaround" to "what will new owners do with the listed vehicle", with outcomes ranging from capital injection and diversification to dilution and management attrition.

Verdict: fundamentally weak, governance in transition, and speculative. Absent clarity on the new shareholders' strategy and evidence that Thailand restores margins, the risk/reward is unfavourable for fundamentals-driven investors.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointed / tenureAgeBackground & educationSource

Mr. Kwok Kwan Fai (Joe Kwok)

Chairman, Executive Director; Chair of Nomination Committee

Joined group Apr 1998 (27+ yrs)

52

B.Bus (Accounting), Monash University (1995); audit trainee K.L. Wong & Co.; Manulife unit manager

[AR2025]

Mr. Kwok Kwan Yu (Ken Kwok)

CEO, Executive Director

Joined Dec 1999 (26+ yrs)

48

Secondary education, Hong Kong; controls DEM FACTORY SRL (51%)

[AR2025], [IR2026]

Mr. Liu Zhen

Executive Director

15 May 2026

—

MD of Prestige Wealth Management (since Dec 2022); deputy finance director, Airport City Development (2022); deputy GM, Hong Kong Airlines (2017–2022); holds 19.60%

[ANN-15MAY26], [IR2026]

Mr. Kwok Mau Kwan

Non-Executive Director; co-founder

Since 1986 (39+ yrs)

82

Honorary chairman, Jiangxi Yingtan Optical Industry Association; CPPCC Yujiang District committee member

[AR2025]

Ms. Chan Yin Wah (Mrs. Kwok)

Non-Executive Director; Nomination Committee (from 25 Mar 2026)

Joined Aug 1987 (38+ yrs)

73

Secondary education, Hong Kong

[AR2025], [IR2026]

Mr. Chu Kin Ming

INED; Audit Committee Chair

22 Jun 2019

45

HKICPA; EMBA CUHK (2022); BA Accountancy PolyU; multiple HK listed-company INED/CoSec roles

[AR2025]

Mr. Leung Ka Tin

INED; Remuneration Committee Chair

1 Jan 2025

72

Banking/treasury/corporate finance (FPB Asia, Nedcor Asia, Delta Asia); INED of Gilston Group (2011.HK) and Star Group Asia (1560.HK, from Apr 2026)

[AR2025], [IR2026]

Mr. Hon Ming Sang

INED; Risk Management Committee Chair

1 Jul 2026

—

CFO and company secretary, China Gas Industry Investment Holdings; ex-international audit firm

[ANN-30JUN26]

“—” = not publicly disclosed.

Executive Leadership Team

NameRoleSinceBackground

Mr. Choi Chun Wai

CFO and Company Secretary

Joined 2021; appointed 1 Jan 2025

HKICPA; BBA CUHK (2010); MCG PolyU (2020); KPMG 2010–2017

Directors' Remuneration

Component (HKD K)H1 2024H1 2025H1 2026

Fees

270270293

Salaries and allowances

3,7182,1011,917

Benefits in kind

685344

Retirement contributions

181818

Total

4,0742,4422,272

Shareholding Trend

Holder30 Jun 202531 Dec 202530 Jun 2026Post 24 Jul 2026Source

Conquer Holding Ltd (Kwok family: Joe 49%, Ken 49%, Mrs. Kwok 2%)

54.19%54.19%29.59%0.00%

[IR2025], [AR2025], [IR2026], [ANN-29JUL26]

Ms. Hu Xing (independent third party)

———29.59%

[IR2026]

Mr. Liu Zhen (Executive Director)

——19.60%19.60%

[IR2026]

Ms. Tam Man Yee

——10.00%10.00%

[IR2026]

Mr. Kwok Hon Yim

5.04%5.45%

not listed (<5%)

not listed

[IR2025], [AR2025], [IR2026]

Mr. Leung Ka Tin (INED)

1.00%1.00%

not listed

not listed

[IR2025], [AR2025], [IR2026]

Competitive Landscape

Key Competitors

CompetitorListingSegment overlapLatest revenueRelative positioning vs KelfredSource

Arts Optical International

1120.HK

ODM frames & sunglasses; also lenses, distribution, own brands

HK$1,333.9m (FY2025)

~2.7x Kelfred's revenue; diversified into lenses and Asia; factories in China, Vietnam, lens plant in Malaysia; profitable

[PEER]

Sun Hing Vision Group

0125.HK

ODM eyewear + brand licensing/distribution; Italy largest market

HK$891.0m (FY to Mar 2026)

~1.8x Kelfred's revenue; similar margin squeeze; loss-making; bases outside China

[PEER]

EssilorLuxottica

EL.PA

Vertically integrated frames/lenses/retail; also a customer/benchmark for the industry

—

Global leader; sets price and design trends

—

Safilo Group

SFL.MI

Eyewear design/manufacture/licensing; also outsources to Asian ODMs

—

Mid-tier global; potential customer and competitor

—

Marcolin

Private (Italy)

Licensed eyewear; sources from Asian manufacturers

—

Brand owner/licensee

—

De Rigo

Private (Italy)

Manufacturing, licensing, retail

—

European integrated player

—

Kering Eyewear

Part of Kering

In-house luxury eyewear

—

Insourcing luxury competes with ODM outsourcing

—

Charmant Group

Private (Japan)

Titanium frame manufacturing

—

Higher-end technical frames

—

Mainland Chinese ODM clusters (Shenzhen Henggang, Xiamen, Wenzhou, Danyang, Yingtan)

Mostly private

Volume frame/sunglass ODM

—

Key price competition driving ASP declines

[IR2026] context

Southeast Asian manufacturers (Vietnam/Thailand-based)

Various

Tariff-advantaged production

—

Competitive threat Kelfred is responding to via Thailand

Analyst assessment

“—” = not publicly disclosed.

Peer Comparison FY2025

MetricKelfred FY2025Arts Optical FY2025Sun Hing FY Mar-2026

Revenue (HKD Mn)

500.31,333.9891.0

Revenue growth (%)

10.34.07.6

Gross margin (%)

11.931.410.9

Net margin (%)

-3.01.6-5.2

Employees (approx.)

7523,4003,000

Company Snapshot

$64.2M

Revenue

768

Employees

1986

Founded

P.O. Box, Cayman Islands

Headquarters

SWOT Analysis

Strengths

  • Net cash, lease-only year-end debt: net cash ≈ HK$22.3m and gearing 5.3% at 30 Jun 2026 [IR2026].
  • Revenue scale recovery: record FY2025 revenue of HK$500.3m, +10.3% YoY [AR2025].
  • Long customer tenure: top customer contributed HK$68.4m (31%) in H1 2026, indicating embedded relationships [IR2026].
  • Owned manufacturing asset: self-owned Jiangxi base, bankable as collateral (secured RMB18.95m and 5.0m loans July 2026) [IR2026].
  • Tax efficiency: HNTE 15% rate and 200% R&D super-deduction at PRC subsidiaries [IR2026].
  • Cost discipline demonstrated: staff costs cut from HK$129.3m (FY2024) to HK$107.1m (FY2025) [AR2025].

Weaknesses

  • Thin and falling gross margin: 10.5% in H1 2026 vs 16.3% in FY2022 [IR2026], [AR2025].
  • Persistent losses: cumulative net loss FY2024–H1 2026 ≈ HK$48.9m (derived) [AR2025], [IR2026].
  • Concentration: top-3 customers 49–59% of half-year revenue [IR2025], [IR2026].
  • Earnings reliant on non-operating items: FY2023 profit (HK$1.4m) only achieved with HK$24.1m other income [AR2025].
  • Working capital dependence on factoring: factored receivables swung HK$39.4m → HK$102.4m → HK$44.5m within 18 months [IR2025], [IR2026].
  • No internal audit function [AR2025].

Opportunities

  • Thailand base to serve tariff-sensitive (US) customers; production expected H2 2026 [IR2026].
  • New market wins: Spain HK$14.9m from zero in H1 2026 [IR2026].
  • Design-fee monetisation: design + service fees HK$4.5m in H1 2026 vs HK$0.5m (design+services subset ex-moulds, H1 2024 ≈ HK$1.3m) [IR2026], [IR2025].
  • New shareholder capital/strategy: fragmented new holders (Hu 29.59%, Liu 19.60%, Tam 10.00%) could inject capital or businesses [IR2026].
  • Asset monetisation: Jiangxi land and buildings could be redeployed or refinanced [IR2026].
  • Peer rationalisation: loss-making peers (e.g., Sun Hing net loss ≈ HK$45.9m) may cede capacity/customers [PEER].

Threats

  • ASP deflation: management explicitly cites competitive decline in ASPs as the main revenue driver of H1 2026 decline [IR2026].
  • RMB appreciation: net FX losses HK$3.1m in H1 2026 and HK$2.8m in H1 2025 [IR2026].
  • European demand weakness: Italy −16%, UK −22% in H1 2026 [IR2026].
  • Trade barriers: US deliveries −29% in H1 2026; trade frictions cited as key 2026–27 risk [IR2026].
  • Governance/strategy discontinuity: founding family exited ownership but remains in executive control [ANN-29JUL26].
  • Customer loss risk: Customer C revenue fell 67% YoY in H1 2026 (HK$33.8m → HK$11.2m) [IR2026].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
29 Apr 2025FY2024 annual report published: revenue +15.3% to HK$453.6m, net loss HK$21.6m, GM 9.8% [AR2024s]Confirms margin collapse
29 May 2025AGM: auditor reappointment (Zhonghui Anda), director re-elections, general issue mandate AGM notice coverageRoutine; issue mandate retains dilution optionality
9 Jul 2025New secured RMB4.0m bank loan [IR2025] note 19Seasonal working capital; PRC property pledged
28 Jul 2025New secured RMB10.95m bank loan [IR2025] note 19Same
Aug 2025 (pre-26 Aug)Positive profit alert: H1 2025 loss expected ~HK$4.7m vs HK$12.3m Profit alert coverageSignals operating recovery
25 Aug 2025INED Hong Sze Lung joins Ocean Star Technology board [IR2025]Director time-commitment disclosure
26 Aug 2025H1 2025 results: revenue +22.8% to HK$242.5m; GM 12.9%; loss HK$4.7m; employees 830 [IR2025]High-water mark of recovery
5 Jan 2026New secured RMB5.0m bank loan (repayable Jan 2027) [AR2025]Working capital
22 Jan 2026New secured RMB9.95m bank loan [AR2025]Working capital
4 Feb 2026Hong Sze Lung redesignated executive director of Sincere Watch (HK) [AR2025]Independence/time considerations
25 Mar 2026FY2025 results: revenue +10.3% to HK$500.3m (record); GP +32.7%; net loss HK$15.2m; no dividend [AR2025]Volume up, ASP down; FX headwind
25 Mar 2026Thailand production base disclosed as strategic priority [AR2025]Tariff/cost diversification
25 Mar 2026Ms. Chan Yin Wah appointed to Nomination Committee [IR2026]Gender-diversity compliance
18 Apr 2026INED Leung Ka Tin appointed INED of Star Group Asia (1560.HK) [IR2026]Director disclosure
29 Apr 2026FY2025 annual report and ESG report published; Conquer still at 54.19% [AR2025]Last report under family control
30 Apr 2026Hong Sze Lung resigns as ED of Sincere Watch [IR2026]Director disclosure
Late Apr – mid May 2026Conquer sells ~123m shares (24.6%); Liu Zhen acquires 98m (19.6%) [IR2026] (dates/prices not disclosed)Start of founding-family exit
15 May 2026Liu Zhen appointed executive director [ANN-15MAY26]New shareholder takes board seat
28 May 2026AGM circular: general mandates to issue/repurchase shares, re-elections, auditor HKEX listingRoutine
By 30 Jun 2026Ms. Tam Man Yee becomes 10% substantial shareholder [IR2026]Further register fragmentation
29 Jun 2026AGM held; poll results published HKEX listingRoutine
30 Jun 2026INED change announced: Hon Ming Sang in, Hong Sze Lung out (effective 1 Jul) [ANN-30JUN26]Board refresh aligned with ownership change
9 Jul 2026New secured RMB5.0m bank loan [IR2026] note 19Working capital
24 Jul 2026Conquer transfers its remaining 147.952m shares (29.59%) to Ms. Hu Xing [ANN-29JUL26]Kwok family fully exits; no controlling shareholder
29 Jul 2026Disposal announcement; board expects no adverse effect on eyewear operations, continues to explore diversification [ANN-29JUL26]Signals possible strategic change
29 Jul 2026New secured RMB18.95m bank loan (largest in series) [IR2026] note 19Higher seasonal funding need amid H1 cash burn
31 Aug 2026H1 2026 results: revenue −9.5% to HK$219.6m; GM 10.5%; loss HK$12.1m; cash HK$29.9m; no interim dividend [IR2026]Recovery reversed

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

6 charts
Income Statement: Revenue & Gross Profit: Revenue rose from HKD 434.7 Mn in FY2021 to HKD 500.3 Mn in FY2025.
Kelfred Holdings Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue434.7465.4393.3453.6500.3
Cost of sales366.3389.4336.3408.9440.9
Gross profit68.4765744.759.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.